Market Currents
OSI Pharmaceuticals (OSIP) moves up 1.1% as the FDA extends the review date of its lung cancer...
-
Friday, January 15, 2010, 1:33 PM ETOSI Pharmaceuticals (OSIP) moves up 1.1% as the FDA extends the review date of its lung cancer drug Tarceva 90 days, to April 18.
Other date
Latest Articles
